(c) 2024 PillSync.com

Guanfacine Guanfacine 1 MG Oral Tablet

INDICATIONS AND USAGE Guanfacine tablets are indicated in the management of hypertension. Guanfacine tablets may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.

Mylan Pharmaceuticals Inc.


8 years ago ROUND WHITE M G4 Guanfacine  Guanfacine 1 MG Oral Tablet

ROUND WHITE M G4

8 years ago ROUND WHITE M G4 Guanfacine  Guanfacine 1 MG Oral Tablet

M G4 ROUND WHITE

HOW SUPPLIED Guanfacine Tablets, USP are available containing guanfacine hydrochloride, USP equivalent to 1 mg or 2 mg of guanfacine. The 1 mg tablets are white, round, unscored tablets debossed with M on one side of the tablet and G4 on the other side. They are available as follows: NDC 0378-1160-77 bottles of 90 tablets NDC 0378-1160-01 bottles of 100 tablets The 2 mg tablets are blue, round, unscored tablets debossed with M on one side of the tablet and G5 on the other side. They are available as follows: NDC 0378-1190-77 bottles of 90 tablets NDC 0378-1190-01 bottles of 100 tablets Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. Revised: 5/2017 GUAN:R7


More pills like ROUND M G4












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site